Definium Therapeutics, Inc. (DFTX) vs Indivior Pharmaceuticals Inc (INDV)
A side-by-side comparison of Definium Therapeutics, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DFTX
Definium Therapeutics, Inc.
$35.61HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
INDV
Indivior Pharmaceuticals Inc
$35.56HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
Total return — DFTX vs INDV
growth of $100 · dividends reinvested · last 10yDFTX +971.9% (+26.8%/yr)INDV +68.2% (+5.3%/yr)DFTX compounded faster over this window
Log scale — wide-divergence pair
DFTX INDV
DFTX vs INDV: by the numbers
- •DFTX is the larger company ($4.73B vs $4.44B market cap).
- •INDV is profitable (26.65% net margin) while DFTX runs a net loss (0.00%).
- •INDV pays a dividend (1.32% yield), while DFTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DFTX | INDV |
|---|---|---|
| P/E ratio | N/A | 12.75 |
| Forward P/E | N/A | 8.42 |
| P/S ratio | N/A | 3.33 |
| P/B ratio | 5.15 | N/A |
| EV / EBITDA | N/A | 8.86 |
Profitability
| Metric | DFTX | INDV |
|---|---|---|
| Gross margin | 0.00% | 83.86% |
| Operating margin | 0.00% | 21.39% |
| Net margin | 0.00% | 26.65% |
| ROE | -38.51% | N/A |
| ROIC | -23.81% | N/A |
Dividends
| Metric | DFTX | INDV |
|---|---|---|
| Dividend yield | N/A | 1.32% |
| Payout ratio | N/A | 17.03% |
Growth (annualized)
| Metric | DFTX | INDV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.88% |
| Total return CAGR (5Y) | 1.43% | 19.65% |
Frequently asked
- Does DFTX or INDV pay a bigger dividend?
- INDV pays a dividend (1.32% yield), while DFTX has no payments in the available dividend history.
- Is DFTX or INDV more profitable?
- INDV runs the higher net margin — DFTX at 0.00% versus INDV at 26.65%.
- How have DFTX and INDV total returns compared?
- Over the past 5 years, DFTX delivered 1.43% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Indivior Pharmaceuticals P/E ratioIndivior Pharmaceuticals dividend yieldDefinium Therapeutics ROEIndivior Pharmaceuticals ROEDefinium Therapeutics operating marginIndivior Pharmaceuticals operating marginDefinium Therapeutics revenue growthIndivior Pharmaceuticals revenue growthDefinium Therapeutics free cash flowIndivior Pharmaceuticals free cash flow
Definium Therapeutics & Indivior Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.